Stocks
Definium Therapeutics Prices $700M Public Offering
Definium Therapeutics announced the pricing of an upsized public offering, raising approximately $700 million in gross proceeds.
Definium Therapeutics announced the pricing of an upsized public offering, raising approximately $700 million in gross proceeds.